Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
34.01%
Operating Margin
10.93%
Net Margin
9.24%
Efficiency Metrics
Revenue per Expense Ratio
1.12
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
29.42%
Income Tax Rate
-222.75%
EPS
1.0900000000
Balance Sheet Analysis
Current Ratio
0.83
Cash Ratio
0.04
Working Capital
$-2.93B
Debt to Equity
2.31
Debt to Assets
45.93%
Equity Ratio
19.92%
Cash Flow Analysis
Operating Cash Flow Ratio
19.43%
Free Cash Flow Ratio
-20.33%
CapEx to Revenue
39.77%
Dividends Paid
No dividends paid
Stock Buybacks
No buybacks
Total Shareholder Returns
No shareholder returns
Cash Position Change
-32.95%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
12.68%
Net Income
24.37%
EPS
19.78%
Operating Income
1.56%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-76.03%
Operating Cash Flow
27.57%
Free Cash Flow
15.28%
Balance Sheet Health
Assets
5.95%
Debt
7.83%
Book Value per Share
5.52%
Inventory
3.33%
Shareholder Returns
Dividends per Share
0.00%
Shares Outstanding
3.88%
Long Term Trends
3Y Revenue/Share
-19.45%
5Y Revenue/Share
-63.49%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%